MRWAH AHMAD: Open Payments
NPI 1750020939 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$638 in 36 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $33 · 2025 $638
Food & beverage: $638
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $179 |
| ABBVIE INC. | 14 | $161 |
| Alkermes, Inc. | 5 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $73 |
| E.R. Squibb & Sons, L.L.C. | 3 | $47 |
| Teva Pharmaceuticals USA, Inc. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: VRAYLAR, ARISTADA, REXULTI, ABILIFY MAINTENA, CAPLYTA, COBENFY, UZEDY, SPRAVATO.
Industry payments across AZ — which companies pay providers there.
